File this under ‘How embarrassing!’

The U.S. National Institutes of Health Clinical Center has suspended operations of its pharmaceutical development section – and ended production of drugs used for 46 clinical trials - after FDA inspectors last month found what were called “serious manufacturing problems and lack of compliance with standard operating procedures.”

Specifically,...